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The voltage-sensing phosphatase (VSP) has changed the way we think about both cellular electrical
activity and PIPs (phosphatidylinositol phosphates). Originally discovered in 1999 (Chen et al.,
1999), these proteins were not recognized as electrically-controlled enzymes until 2005 (Murata
et al., 2005). They constitute the first, and so far the only, example of an enzyme linking electrical
signals at the plasma membrane to the catalysis of PIPs (Murata et al., 2005), a ubiquitous family of
intracellular signaling molecules (Di Paolo and De Camilli, 2006; Balla, 2013). Before the discovery
of VSP, there were no known direct links between the two. Textbook examples would represent this
connection with arrows, alluding to indirect or “yet-to-be-defined” signaling pathways. Now we
know that VSP serves as a direct connection between the electrical nature of the cell and PIPs, lipid
second messengers that are critical for cell survival. However, many questions remain unanswered
regarding VSP and its electrical regulation of cellular processes.
With the discovery of VSP, the membrane potential must now be considered when studying PIP
regulators. PIPs are involved in almost all aspects of cell physiology from survival, proliferation,
and migration to pre-programed cell death (Di Paolo and De Camilli, 2006; Logothetis et al.,
2010; Koch and Holt, 2012; Balla, 2013). For example, PIP concentrations are actively polarized
in migrating cells with phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3 ) on the leading edge
and phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2 ) on the lagging edge (Leslie et al., 2008).
These gradients in the concentration of PIPs are necessary for activation of Rac and Rho leading
to cell motion. PIPs are also crucial for cell growth: PI(3,4,5)P3 activates the mTor cascade
leading to increased protein, membrane, and nucleic acid production (Dibble and Manning, 2013).
Many human diseases have been associated with altered homeostasis of PIPs, including cancer,
developmental disorders, and Alzheimer’s disease (Simpson and Parsons, 2001; McCrea and De
Camilli, 2009; Hakim et al., 2012). Though the physiological relevance of VSP is not yet defined, it
is still crucial to human health to understand how PIPs are regulated and that now includes VSP.
All cells have an asymmetric composition of ions across their plasma membrane, which,
combined with selective permeabilities for these ions, results in a difference in the electrical
potential across their plasma membrane. This difference, called the membrane potential, constitutes
a form of cell signaling and a source of energy, both driving many biological processes. This
electrical potential difference powers neuronal excitability as well as more general processes like
proliferation, migration, and development (Levin, 2007; Sundelacruz et al., 2009; Yao et al., 2011).
Regulation by the membrane potential has long been the sole purview of ion channels and
transporters and that has influenced what questions are asked regarding the changing potential.
With our new knowledge of VSP, the changing membrane potential can directly signal the cell
by modulating mTor and cell growth pathways, leading to abnormal growth or the M-current in
sympathetic ganglion, leading to hyperexcitability.
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Voltage-controlled enzyme signaling

The articles in this Special Topic highlight several features
of VSP including its unique activation, its similarities to other
enzymes and its use as a versatile tool to study other proteins.
In the review article by Hobiger and Friedrich (2015, p. 20),
the authors compare the structural similarities and differences
between the broader family of protein tyrosine phosphatases
and one of its newest members, VSP. They suggest a catalytic
mechanism based on this comparison. Castle et al. (2015, p. 63)
investigate the activation mechanism of VSP by probing the C2
domain, the C-terminal domain of VSP that has been largely
unrecognized before the recent crystal structures showed a direct
contribution of the C2 residue Y522 into the active site. The work
by Mavrantoni et al. (2015, p. 68) explores the techniques that are
used to test VSP and address some of their limitations including
the need for expensive electrophysiology equipment as well as the
limitations of using channels as functional reporters. They take
their methods and apply them to a chimera between the Ciona
intestinalis VSP and human PTEN and show how the chimera
allows for the investigation of PTEN using standard techniques
but with the advantage of regulated activation, voltage.
Beyond the molecular mechanism underlying VSP activity,
Mori et al. (2015, p. 22) review the use of VSP as a relatively
simple tool for manipulating PI(4,5)P2 concentrations in cells.
They have used VSP to study the PI(4,5)P2 regulation of transient
receptor potential canonical channels involved in receptoroperated calcium currents. Along the same lines, Rjasanow

et al. (2015, p. 127) use VSP as a tool that gives them precise
control over the PI(4,5)P2 concentrations in the membrane.
These authors compared the relative PIP affinities between
several ion channels. They also point out an important limitation
that the channels must already have a known specificity for a
particular PIP because VSP does not destroy PIPs in contrast to
phospholipase C; instead, it generates multiple PIPs. All together,
these articles underscore the features of VSP and expand our
understanding of its function and utility.
Though VSP remains relatively unknown to many, this
nascent field has shown fast initial growth. The unique nature
of these enzymes has inspired many to investigate their
properties as well as take advantage of them. Many questions
remain unanswered regarding VSP such as how the voltage
sensor couples to the enzyme and whether the phosphatase
domain is brought to the membrane for activation or whether
a conformational change within the active site determines
activation. We look forward to the studies that will address these
and the many other questions that persist in this exciting field.
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